UNCY,Unicycive Therapeutics, Inc. | Healthcare

Healthcare

UNCY

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Unicycive Therapeutics, Inc.UNCY

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States.

It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI 494, which is in Phase 1 clinical trials for treatment of acute kidney injury.

The company was incorporated in 2016 and is based in Los Altos, California.

Latest News >

Deutsche Bank's U.S. operations deemed 'troubled' by the Federal Reserve last year, says report

Jun 1, 2018

The United States Federal Reserve last year designated Deutsche Bank AG's U.S. operations to be in troubled condition, The Wall...

Indian manufacturing PMI growth slows in May, inflationary pressures pick up

Jun 1, 2018

Activity in India's manufacturing sector grew at a weaker pace in May from the previous month, a business survey showed...

Expect reasonably good profits in FY19 ahead of good monsoon predictions, says NHPC

Jun 1, 2018

We are going to have a reasonably good profit this time as the IMD has predicted that the monsoon is...

Free trade talks between China and Sri Lanka hit big hurdles

Jun 1, 2018

Talks between China and Sri Lanka for a free trade agreement have hit major hurdles, mainly because Beijing will not agree to Colombo's demand for a review of the deal after 10 years